Choon Choong - Mar 18, 2024 Form 4 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
10%+ Owner
Signature
/s/ Choon Choong Hau
Stock symbol
TTNP
Transactions as of
Mar 18, 2024
Transactions value $
-$500,000
Form type
4
Date filed
3/27/2024, 09:45 AM
Previous filing
Jul 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TTNP Common Stock Conversion of derivative security $0 +54.1K +1.44% $0.00 3.8M Mar 18, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TTNP Convertible Promissory Note Conversion of derivative security -$500K 0 Mar 18, 2024 Common Stock 54.1K $9.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 18, 2024, the Reporting Person converted an aggregate of $500,000 of the outstanding principal and $6,444.44 of the outstanding accrued interest, including $1,933.33 of tax withholding on interest earned, for a total sum payable of $504,501.11 under the Convertible Promissory Note issued by Issuer dated August 8, 2023. After giving effect to the conversion, as of the date of this Form 4, there are no outstanding in principal or in accrued interest outstanding under the Convertible Promissory Note.